2023
DOI: 10.1128/jvi.00160-23
|View full text |Cite
|
Sign up to set email alerts
|

Harnessing the Noncanonical Keap1-Nrf2 Pathway for Human Cytomegalovirus Control

Abstract: Antiviral treatment for human cytomegalovirus (HCMV) is limited and suffers from the selection of drug-resistant viruses. Several cellular pathways have been shown to modulate HCMV replication.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 65 publications
0
0
0
Order By: Relevance